Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis.

Studies measuring the fibrin degradation product D-Dimer (DD) using enzyme-linked immunosorbent assays (ELISA) in patients with venographically proven deep venous thrombosis (DVT) suggest that it is possible to exclude DVT when DD level is below a certain cut-off level. However, ELISA methods are time-consuming and not available in all laboratories. Different rapid latex-agglutination assays have been investigated, but their sensitivity is considerably lower. In the present study we compared the value of four novel latex DD tests (Tinaquant, Minutex, Ortho and SimpliRed) and one rapid ELISA (VIDAS) to a classical ELISA DD assay (Organon Mab Y18) in 132 patients suspected of DVT. The VIDAS, a new quantitative automated ELISA, had a sensitivity of 100% and a negative predictive value of 100% for both proximal and distal DVT at a cut-off level of 500 ng/ml. The Tinaquant assay, a new quantitative latex method, had a sensitivity of 99% and a negative predictive value of 93% for both proximal and distal DVT at a cut-off level of 500 ng/ml. For proximal DVT only, both assays had a sensitivity and negative predictive value of 100%. VIDAS and Tinaquant correlated well with ELISA (correlation of r = 0.96 and r = 0.98 respectively). Sensitivities of the semi-quantitative latex assays Minutex, Ortho and SimpliRed were considerably lower (77%, 51% and 61% respectively). These results suggest that VIDAS and Tinaquant may be used instead of ELISA DD in the exclusion of DVT. Tinaquant can be performed within 20 min and VIDAS within 35 min. Both assays might be used as a routine screening test and should be evaluated in large clinical management studies.

CAPD patients exhibit a nocturnal fall in blood pressure: a single-centre study.

BACKGROUND: In 29 CAPD (continuous ambulatory peritoneal dialysis) patients the height and diurnal variation of the blood pressure (BP) and heart-rate (HR) were analyzed by means of 24-hour ambulatory blood pressure monitoring (ABPM). METHODS: Normal diurnal variation was defined as a fall of 10% or more during nighttime (NT) compared with daytime (DT) BP or HR (DT = 10.00 a.m.-9.00 p.m., NT = midnight-06.00 a.m.). To evaluate high BP in the course of time we used the concept of "whole-day BP load", defined as the percentage of BP readings above 140/90 mmHg during a 24-h period. A "hypertensive BP load" was defined as a systolic BP (SBP) load of more than 50% and/or a diastolic BP (DBP) load in excess of 40%. In addition to analysis of the circadian rhythm of BP and HR and the prevalence of a hypertensive BP load in CAPD patients, the influence of various factors such as gender, creatinine clearance, recombinant human erythropoietin, antihypertensive medication, haematocrit, whole-day BP load, and the nightly dialysis glucose concentration on the diurnal variation of BP and HR were studied. RESULTS: Based on the 95% confidence intervals for the proportional nocturnal decrease, normal diurnal variation of BP and HR was present in most CAPD patients. No correlation could be demonstrated between a blunted circadian rhythm and the variables mentioned above. However, when other time-period definitions (DT = 6.00 a.m.-11.00 p.m., NT = 11.00-6.00 and DT = 8.00 a.m.-8.00 p.m., NT = 8.00 p.m.-8.00 a.m.) were applied to the data, considerably fewer patients displayed normal diurnal variation. Whereas all patients showed normal home BP readings, ABPM of 21 out of 29 patients displayed a hypertensive BP load. CONCLUSION: The majority of our CAPD patients exhibited normal diurnal variation of SBP and DBP depending, however, on the definitions of DT and NT used. The absence of a normal circadian rhythm could not be explained by any of the variables analyzed. Surprisingly, uncontrolled hypertension, as defined by a hypertensive BP load, was found in 72% of the patients.